UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)... Read more.
ResumeTemplates.com Survey: Hiring Managers Reveal the Most Important Hard and Soft Skills for 2026
Communication and software skills top the list as employers balance technical ability and professionalism SEATTLE, Dec. 8, 2025 /PRNewswire/ — A new ResumeTemplates.com... Read more.
Riyadh Air and IBM Partner to Launch World’s First AI-Native Airline
Riyadh Air’s AI‑powered operations create agility across the business and unify employee and guest experiences, setting a new benchmark in aviation RIYADH,... Read more.
AsymBio Commences Commercial Operations at Fengxian Base, Strengthening Global Biopharmaceutical CDMO Capabilities
SHANGHAI, Dec. 8, 2025 /PRNewswire/ — AsymBio, a technology-driven global Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem... Read more.
Binance Becomes First Crypto Exchange To Secure a Global License Under ADGM Framework, Setting a New Standard in Digital-Asset Regulation
ABU DHABI, UAE, Dec. 7, 2025 /PRNewswire/ — Binance, the world’s largest cryptocurrency exchange by trading volume and users, today announced a landmark... Read more.
CIMC Unveils New Global Brand Logo and Visual Identity System
SHENZHEN, China, Dec. 7, 2025 /PRNewswire/ — On December 5, 2025, China International Marine Containers (Group) Co., Ltd. (CIMC) unveiled its new brand logo... Read more.
Median PFS Trending Beyond One Year: Leads Biolabs’ LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting
NANJING, China, Dec. 7, 2025 /PRNewswire/ — From December 6 to 9, 2025, the 67th Annual Meeting of the American Society of Hematology (“ASH”) was... Read more.
IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH
SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 7, 2025 /PRNewswire/ — IASO Biotechnology (“IASO Bio”), a commercial-stage biopharmaceutical... Read more.
HD Hyundai Signs MOU with Indian State Government to Establish New Shipyard
Signed an exclusive business agreement with the Tamil Nadu state government to promote the establishment of a new shipyard Tamil Nadu state assessed as the most... Read more.
Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
TOKYO, Dec. 7, 2025 /PRNewswire/ — The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 70 million (USD... Read more.